18 Medicine of the week: Bevacizumab

Discover bevacizumab, a monoclonal antibody targeting VEGF to inhibit tumor angiogenesis in cancers like colorectal, lung, and ovarian. Understand its mechanism, side effects such as hypertension and bleeding, and its unique role in combination regimens. Explore its safety considerations and clinical applications.